Edition:
India

Biofrontera AG (B8FGn.DE)

B8FGn.DE on Xetra

5.18EUR
18 Oct 2019
Change (% chg)

€-0.01 (-0.19%)
Prev Close
€5.19
Open
€5.28
Day's High
€5.28
Day's Low
€5.10
Volume
28,051
Avg. Vol
72,207
52-wk High
€8.07
52-wk Low
€4.78

Latest Key Developments (Source: Significant Developments)

Biofrontera 9-Mth Sales At About EUR 18.9 To 19.2 Mln
Thursday, 10 Oct 2019 

Oct 10 (Reuters) - BIOFRONTERA AG ::REPORTS PRELIMINARY UNAUDITED SALES REVENUE FOR THE FIRST NINE MONTHS OF 2019.SALES OF APPROXIMATELY EUR 18.9 TO 19.2 MILLION IN PERIOD FROM JANUARY 1ST TO SEPTEMBER 30TH, 2019.COMPANY CONTINUES TO SEE Q4 AS KEY REVENUE DRIVER FOR ITS GROWING BUSINESS IN ALL MARKETS.  Full Article

Biofrontera AG H1 Sales Of About EUR 13.8-14.0 Mln
Tuesday, 9 Jul 2019 

July 9 (Reuters) - Biofrontera AG ::DGAP-NEWS: BIOFRONTERA AG: BIOFRONTERA REPORTS PRELIMINARY UNAUDITED SALES REVENUE FOR THE FIRST SIX MONTHS OF 2019.H1 SALES OF ABOUT EUR 13.8 TO 14.0 MILLION.H1 SALES OF AMELUZ IN U.S. WERE BETWEEN EUR 9.5 AND 9.7 MILLION, COMPARED TO EUR 6.4 MILLION (+50%) YEAR AGO.REVENUE IN GERMANY INCREASED BY ABOUT 82% TO EUR 2.1 TO 2.2 MILLION IN FIRST HALF OF 2019.  Full Article

Biofrontera Removes AGM Agenda Item Including Dr. Granzer's Removal From Supervisory Board
Friday, 5 Jul 2019 

July 5 (Reuters) - BIOFRONTERA AG ::DISMISSING AGM AGENDA ITEM 10 (INCLUDING THE REMOVAL OF DR. GRANZER FROM THE SUPERVISORY BOARD).IF UNDER ITEM 11 OF AGENDA DR. ING. BORER IS REMOVED FROM SUPERVISORY BOARD, TO PROPOSE PROF. DR. FRANCA RUHWEDEL TO SUCCEED DR. BORER.  Full Article

Biofrontera: Board Recommends Not To Accept Deutsche Balaton And Delphi Offer
Monday, 1 Jul 2019 

July 2 (Reuters) - Biofrontera AG ::SAID ON MONDAY IN A JOINT STATEMENT, EXECUTIVE BOARD AND MANAGEMENT BOARD OF BIOFRONTERA AG RECOMMEND NOT TO ACCEPT THE PARTIAL ACQUISITION OFFER OF DEUTSCHE BALATON BIOTECH AG AND DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFT.THE EMPLOYEES OF BIOFRONTERA AG ALSO REJECT THE PARTIAL ACQUISITION OFFER OF DEUTSCHE BALATON BIOTECH AG AND DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFT IN AN OWN STATEMENT.  Full Article

Biofrontera Nominates Franca Ruhwedel To Supervisory Board As Hansjörg Plaggemars Successor
Tuesday, 4 Jun 2019 

June 4 (Reuters) - BIOFRONTERA AG ::NOMINATES NEW CANDIDATE FOR THE SUPERVISORY BOARD.SUPERVISORY BOARD PROPOSES THAT PROF. DR. FRANCA RUHWEDEL BE ELECTED TO SUPERVISORY BOARD AS SUCCESSOR TO HANSJÖRG PLAGGEMARS.  Full Article

Deutsche Balaton Sets Compensation Price To Shareholders Of Biofrontera At EUR 7.20/Shr
Friday, 31 May 2019 

May 31 (Reuters) - Deutsche Balaton Ag ::COMPENSATION FOR VOLUNTARY ACQUISITION OFFER TO SHAREHOLDERS OF BIOFRONTERA SET AT EUR 7.20PER SHARE.  Full Article

Biofrontera Q1 Net Loss At EUR 3.0 Mln
Wednesday, 29 May 2019 

May 29 (Reuters) - BIOFRONTERA AG ::REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.TOTAL REVENUE INCREASED 46% TO EUR 6.8 MILLION IN Q1 2019 COMPARED TO EUR 4.7 MILLION IN Q1 2018;.Q1 NET LOSS WAS EUR 3.0 MILLION OR 6 CENTS PER SHARE IN Q1 2019 COMPARED TO EUR 3.2 MILLION OR 8 CENTS PER SHARE IN Q1 2018.CASH AND CASH EQUIVALENTS WERE EUR 21.8 MILLION AS OF MARCH 31, 2019.OUTLOOK 2019: EXPECTS ANNUAL SALES OF AROUND EUR 35-40 MILLION.OUTLOOK 2019: RESULT FROM OPERATING ACTIVITIES OF EUR -7 TO -9 MILLION.  Full Article

Maruho Says Decides To Increase Offer Price To EUR 7.20/Shr Of Biofrontera
Thursday, 23 May 2019 

May 23 (Reuters) - Maruho Deutschland GmbH::SAYS DECIDES TO INCREASE OFFER PRICE TO EUR 7.20 PER SHARE OF BIOFRONTERA AG <<>>.MARUHO WILL OFFER SHAREHOLDERS EUR 7.20 PER SHARE IN CASH (PREVIOUSLY: EUR 6.60).MARUHO SAYS NEW OFFER PRICE AT PREMIUM OF 27.21% ON XETRA CLOSING PRICE OF BIOFRONTERA SHARE ON APRIL 1, 2019.MARUHO SAYS OTHER PARAMETERS OF TRANSACTION REMAIN UNAFFECTED BY INCREASE OF OFFER PRICE.  Full Article

Deutsche Balaton Biotech AG Says It Intends To Change Composition Of Management Board And Supervisory Board Of Biofrontera AG
Thursday, 23 May 2019 

May 22 (Reuters) - Biofrontera AG ::DEUTSCHE BALATON BIOTECH AG SAYS INTEND TO CHANGE COMPOSITION OF MANAGEMENT BOARD AND SUPERVISORY BOARD OF BIOFRONTERA AG - SEC FILING.DEUTSCHE BALATON BIOTECH AG - SUBMITTED A PROPOSAL TO DISMISS THOMAS SCHAFFER, CFO OF BIOFRONTERA AG.DEUTSCHE BALATON BIOTECH AG - SUBMITTED A PROPOSAL TO DISMISS HERMANN LÜBBERT AS THE CHAIRMAN OF THE MANAGEMENT BOARD.DEUTSCHE BALATON BIOTECH AG - SUBMITTED A PROPOSAL TO DISMISS ULRICH GRANZER AS THE CHAIRMAN OF THE SUPERVISORY BOARD OF BIOFRONTERA AG.DEUTSCHE BALATON BIOTECH AG - MADE PROPOSAL SUPPORTING ELECTION OF MARK SIPPEL AS REPLACEMENT MEMBER OF SUPERVISORY BOARD OF BIOFRONTERA.  Full Article

Biofrontera FY Net Loss Narrows To EUR 9.6 Million
Monday, 29 Apr 2019 

April 29 (Reuters) - Biofrontera AG ::FY TOTAL REVENUE INCREASED 76% TO EUR 21.1 MILLION COMPARED TO EUR 12.0 MILLION IN 2017;.FY PRODUCT REVENUE INCREASED 98% TO EUR 21.0 MILLION COMPARED TO EUR 10.6 MILLION IN 2017;.FY NET LOSS WAS EUR (9.6) MILLION OR (0.20) PER SHARE COMPARED TO EUR (15.2) MILLION OR (0.42) PER SHARE IN 2017;.EXPECTS 2019 REVENUE TO BE IN RANGE OF EUR 35 MILLION AND EUR 40 MILLION.2019 LOSS ON OPERATIONS IS EXPECTED TO BE BETWEEN EUR 7 AND EUR 9 MILLION..2019 LOSS BEFORE INCOME TAXES IS EXPECTED TO BE BETWEEN EUR 9 AND 11 MILLION.  Full Article